Navigation Links
Boehringer Ingelheim Broadens Its Breast Cancer Clinical Trial Program for the Investigational Compound Afatinib
Date:9/6/2011

a href="http://clinicaltrials.gov/ct2/show/NCT01125566?term=LUX-Breast+1&rank=1">http://clinicaltrials.gov/ct2/show/NCT01125566?term=LUX-Breast+1&rank=1.

Afatinib in HER2-Treatment Failures (1200.98)

This global, non-randomized, open-label study began in May 2011 and will investigate the efficacy and safety of afatinib alone and in combination with weekly paclitaxel or weekly vinorelbine (in patients who progress on afatinib monotherapy within this trial) as treatment in patients with HER2-overexpressing, metastatic breast cancer, who failed HER2-targeted treatment in the neoadjuvant or adjuvant setting. The study will recruit approximately 120 patients.  The primary endpoint of the study is objective response rate; secondary endpoints include best overall response (OR) during each treatment period, duration of OR, PFS and safety.  For more information, please visit http://clinicaltrials.gov/ct2/show/NCT01271725?term=afatinib+1200.98&rank=1.  

Afatinib in erbB2 (HER2)-Overexpressing Inflammatory Breast Cancer (1200.89)

This non-randomized, open-label study will investigate the efficacy and safety of afatinib alone and in combination with weekly vinorelbine (in patients who progress on afatinib monotherapy within this trial) as treatment in patients with HER2-overexpressing, locally advanced or metastatic inflammatory breast cancer. The study will include approximately 40 patients (combined in the United States and globally) who have or have not failed prior trastuzumab treatment. The primary endpoint of the study is clinical benefit rate assessed by complete response, partial response and stable disease for at least six months; secondary endpoints include OR, duration of OR, PFS and safety.  For more information, please visit

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Dohmen Company CEO ... for the Metropolitan Milwaukee Association of Commerce,s annual ,Future ... at the Pfister Hotel. The ,Future 50, Awards highlights ... businesses and young firms headquartered in the seven-county ... has called Milwaukee home for ...
(Date:9/4/2015)... , Sept. 4, 2015  Luminex Corporation (NASDAQ: ... the Morgan Stanley Global Healthcare Conference to be held ... Hotel in New York City . ... a.m. Eastern time on Friday, September 18, 2015.  The ... Luminex Corporation,s website at http://www.luminexcorp.com . Simply log on ...
(Date:9/4/2015)... According to a new market ... Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis ... Forecast to 2020", published by MarketsandMarkets, the global Apheresis ... 2020, growing at a CAGR of 11.2% during the ... Browse 139 Tables and 45 F igures spread ...
Breaking Medicine Technology:Dohmen CEO Cynthia LaConte to Keynote MMAC 'Future 50' Awards Luncheon 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... NEW YORK, June 2, 2011 Citeline, the world,s ... recently completed a comprehensive review of clinical trial starts ... patterns in drug development. Over the one-year review period ... trials were initiated in the oncology sector, more than ...
... Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today ... Trademark Office of Patent Application Serial No. 12/549458 ... This follows the UK issuance which was granted ... patent estate. The patent covers the ...
Cached Medicine Technology:Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 2Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase 3Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 2Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat 3
(Date:9/4/2015)... Marietta, GA (PRWEB) , ... September 04, 2015 , ... ... team is in desperate need of new apparel. In an effort to assist the ... around Marietta, has launched a charity drive to raise funds for the new uniforms. ...
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco cosmetic dentist ... CEREC is a newer method for creating restorations through innovative imaging equipment and ... the need for multiple appointments, CEREC produces restorations with total precision for a ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The USC ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are honored ... great pride in the quality of our ophthalmology residency program. Our faculty places a ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated their ... supporting families affected by autism, raising nearly $250,000. , 150 guests, including event ... Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings of ...
Breaking Medicine News(10 mins):Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... study conducted by Statistics Canada it said that there is a ... conducted// over a period of eight-year. About 54% of the children ... 2002-2003. There was an increase especially in three forms of child ... relative and care by a relative inside or outside the home. ...
... poultry in Burhanpur district of Madhya Pradesh, which is close to ... villages of Jalgaon have already been tested positive for the H5 ... time that these strains will be identified as H5N1 as the ... ,The Maharashtra government has promised financial assistance of Rs ...
... The ASA has demanded that the television commercials for ‘Head ... of their products, is required to be// modified. Adverts ... are the ones working up more soap than required. ... has clarified its stance, insisting that the advertisement speaks of ...
... is taking up the cause of four men whose lives ... conducted by the German company// TeGenero and medical research company ... Day, who is handling the case, has felt ignored after ... about the tests conducted at Northwick Park Hospital in Harrow, ...
... are to be believed, reducing calories may well extend life. ... appears in this week's Journal of the American Medical Association. ... from Louisiana State University in Baton Rouge, "A lot of ... life span in several animal species. However, there hasn't been ...
... wine may lower the risk of coronary heart attack and could ... ,A 10-year study of 4,400 men and women aged 65 ... in Boston found a link between the amount of alcohol drunk ... Daily Mail. , ,People who drink 14 or more glasses ...
Cached Medicine News:Health News:Child-Care In Canada A Costly Affair 2Health News:Cut down on food to live longer!!! 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: